Table I.
Variables | Patients∗ | Total |
---|---|---|
Patients with COVID-19 (pharyngeal swab-positive) | 678 | |
Italian patients | 92 | |
Chinese patients | 586 | |
Degree of disease severity† | ||
Critical types | 41 (6) | |
Severe types | 118 (17.5) | |
Common types | 127 (18.7) | |
Mild types | 392 (57.8) | |
Patients with COVID19 with skin manifestations | 53 (7.8) | |
Male | 32 (60) | |
Female | 21 (40) | |
Age, y | 55.9 (28-69) | |
Chinese patients | 53.2 (28-65) | |
Italian patients | 58.6 (35-69) | |
Inflammatory skin manifestations related to COVID-19 | 53 | |
Erythematous rash | 37 (70) | |
Diffuse urticaria | 14 (26) | |
Varicelliform rash with vesiculation | 2 (4) | |
Vascular skin manifestations in intensive care patients | ||
Diffuse petechiae, purpura, and acroischemia | 13 | |
Onset of inflammatory skin manifestations related to COVID-19 | 53 | |
Before hospitalization | 23 (44) | |
After hospitalization | 30 (56) | |
Duration of inflammatory skin manifestations, d | 3 (2-5) |
COVID-19, Coronavirus disease 2019.
Patient data are presented as number (%) or mean (range).
Degree of disease severity: For the mild type: slight clinical symptoms with no pneumonia presentation in imaging. For the common type: manifestations such as fever or respiratory presentation with pneumonia by radiography, or both. For the severe type (meeting any of the following conditions): (1) dyspnea, respiration rate 30 times/min; (2) finger oxygen saturation under resting 93%; (3) arterial partial pressure of arterial oxygen/fraction of inspired oxygen 300 mm Hg (1 mm Hg = 0.133 kPa). For the critical type (meeting any of the following conditions): (1) respiratory failure requiring mechanical ventilation; (2) shock; (3) combined with other organ failures requiring an intensive care unit.